Literature DB >> 32484964

Successful treatment of recalcitrant nodular prurigo with tofacitinib.

O E Molloy1, N Kearney1, N Byrne1, B Kirby1.   

Abstract

Entities:  

Year:  2020        PMID： 32484964     DOI： 10.1111/ced.14320

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  3 in total

Review 1.  [Update on the treatment of chronic prurigo].

Authors:  Claudia Zeidler; Manuel Pedro Pereira; Sonja Ständer
Journal:  Dermatologie (Heidelb)       Date:  2022-07-12

Review 2.  Immunotargets and Therapy for Prurigo Nodularis.

Authors:  Angelina Labib; Teresa Ju; Ashley Vander Does; Gil Yosipovitch
Journal:  Immunotargets Ther       Date:  2022-04-26

3.  Tofacitinib for Prurigo Nodularis: A Case Report.

Authors:  Tianhao Li; Pingsheng Hao; Changlan Peng; Chunxiao Li; Yingying Zhou; Qiuyue Wang; Ping Xie
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.